홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

N-(1-acetyl-5-nitro-1H-indazol-3-yl)acetamide → N-(1-acetyl-5-amino-1H-indazol-3-yl)acetamide

HRID 227696
인쇄

반응식

HRID 227696 반응식
[C:1]([N:4]1[C:12]2[C:7](=[CH:8][C:9]([N+:13]([O-])=O)=[CH:10][CH:11]=2)[C:6]([NH:16][C:17](=[O:19])[CH3:18])=[N:5]1)(=[O:3])[CH3:2]>CO.[Pd]>[C:1]([N:4]1[C:12]2[C:7](=[CH:8][C:9]([NH2:13])=[CH:10][CH:11]=2)[C:6]([NH:16][C:17](=[O:19])[CH3:18])=[N:5]1)(=[O:3])[CH3:2]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 1

HCID 57755833N-(1-acetyl-5-nitro-1H-indazol-3-yl)acetamide

생성물 1

HCID 57755866N-(1-acetyl-5-amino-1H-indazol-3-yl)acetamide수율 98%

시약·촉매·용매 2

HCID 23938Palladium촉매HCID 887Methanol용매

실험 절차

The product from Step (b) above (3.0 g, 11.4 mmol) and 5% Pd/C (1 g) were combined in MeOH (40 mL) and hydrogenated uner a balloon of H2 for 3 h. The mixture was filtered through Celite and the filtrate was concentrated to give the title compound as a dark solid (2.6 g, 98%). NMR 1H NMR (400 MHz, DMSO-D6) δ 10.62 (s, 1H), 7.97 (dd, J=7.9, 1.8, 1H), 6.93-6.89 (m, 2H), 5.26 (s, 2H), 2.52 (s, 3H), 2.08 (s, 3H) (MS m/z 233.2 [M+H]+

후처리

  1. filtrationThe mixture was filtered through Celite
  2. concentrationthe filtrate was concentrated

출처 및 근거

ORD 기록
ord-3fa5aba120e84866967b923e5c38957f
출처 데이터셋
uspto-grants-2009_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07560467B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트